Reductions in Anxiety with Increased cGMP

CiteULike: Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling: "Masood, A., Huang, Y., Hajjhussein, H., Xiao, L., Li, H., Wang, W., Hamza, A., Zhan, C.-G., and O'Donnell, J. M. (2009). Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cgmp signaling. Journal of Pharmacology and Experimental Therapeutics, 331(2):690-699."